Ning Jin
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
- Cancer Research top 10%
Papers in
-
- Epigenetics and DNA Methylation 5
- Gut microbiota and health 3
- Cell death mechanisms and regulation 3
- Oncology 17
- Colorectal Cancer Treatments and Studies 4
- Cancer Immunotherapy and Biomarkers 4
- Cancer-related Molecular Pathways 3
- Co-authors
- Barry D. Nelkin (7 shared papers)Douglas W. Ball (7 shared papers)Tianyun Jiang (4 shared papers)Laith Abushahin (5 shared papers)Ashish Manne (2 shared papers)Adithya Chennamadhavuni (1 shared paper)Carolyn J. Presley (1 shared paper)Brendan Collins (2 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancers (4 papers)The Journal of Clinical Endocrinology & Metabolism (3 papers)Frontiers in Immunology (2 papers)Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ning Jin
59 papers receiving 1.4k citations
Ning Jin's Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 544
- Cancer Research 145
- Endocrinology, Diabetes and Metabolism 131
- Molecular Biology 551
- Epidemiology 217
Countries citing papers authored by Ning Jin
This map shows the geographic impact of Ning Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Jin more than expected).
Fields of papers citing papers by Ning Jin
This network shows the impact of papers produced by Ning Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Jin. The network helps show where Ning Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Risk Factors and Biomarkers for Immune-Related Adverse Events: A Practical Guide to Identifying High-Risk Patients and Rechallenging Immune Checkpoint Inhibitors Hit paper breakdown → | 2022 | 220 |
| 2 | 2009 | 151 | |
| 3 | 2005 | 98 | |
| 4 | 2021 | 90 | |
| 5 | 2007 | 79 | |
| 6 | 2011 | 75 | |
| 7 | 2009 | 66 | |
| 8 | 2005 | 59 | |
| 9 | 2020 | 58 | |
| 10 | 2022 | 40 | |
| 11 | 2016 | 38 | |
| 12 | 2021 | 35 | |
| 13 | 2005 | 32 | |
| 14 | 2001 | 30 | |
| 15 | 2022 | 24 | |
| 16 | 2023 | 21 | |
| 17 | 2020 | 20 | |
| 18 | 2021 | 20 | |
| 19 | 2015 | 19 | |
| 20 | 2016 | 19 |
About Ning Jin
Ning Jin is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 65 papers that have together received 1.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Gut microbiota and health (3 papers), interferon and immune responses (3 papers), Cancer Genomics and Diagnostics (3 papers), Cell death mechanisms and regulation (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Oncology (544 citations), Cancer Research (145 citations), Endocrinology, Diabetes and Metabolism (131 citations), Molecular Biology (551 citations) and Epidemiology (217 citations). Ning Jin has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Barry D. Nelkin, Douglas W. Ball, Tianyun Jiang, Laith Abushahin, Ashish Manne, Adithya Chennamadhavuni, Carolyn J. Presley, Brendan Collins, Dina Rosen and William Matsui. Their work appears in journals such as Journal of Clinical Oncology, Cancers, The Journal of Clinical Endocrinology & Metabolism, Frontiers in Immunology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.